Tilray Medical Brings Free Cannabis Care to Veterans at Aldershot Armed Forces Weekend

Tilray Medical (Tilray Brands, Inc.; NASDAQ: TLRY) is using Armed Forces Weekend in Aldershot to expand awareness and access to regulated medical cannabis for veterans and service families in the UK. Its Lyphe Clinic subsidiary will bring a dedicated “Lyphe for Veterans” access program directly into the heart of a large military community gathering.

What Tilray Medical and Lyphe are doing

Lyphe Clinic, Tilray’s UK medical‑cannabis clinic, will host a stand at Aldershot’s Armed Forces Weekend on June 27–28 to engage veterans, serving personnel, families, and local organizations. The team will explain how Lyphe for Veterans works, walk people through the clinical assessment process, and answer questions about medical cannabis in a setting that’s focused on recognition and support rather than marketing alone.

Launched in late 2025, Lyphe for Veterans is open to veterans of any nationality aged 18 or older who live in the UK or Channel Islands and can prove their veteran status. The program aims to remove clinic‑related financial barriers by covering

• Initial consultation fees.
• Follow‑up appointment fees.
• Summary Care Record handling.
• Repeat prescription request and delivery fees via Lyphe Dispensary.

Why Aldershot matters

Aldershot is home to one of the UK’s largest Armed Forces and veteran populations, and Armed Forces Weekend is expected to draw 20,000–40,000 attendees. That makes it a natural place to offer face‑to‑face information about medical cannabis access, especially for people who may not be aware that prescription‑only cannabis‑based medicines are available through specialist clinical assessment in the UK.

By appearing at the event, Tilray Medical and Lyphe are signaling that their focus is on regulated, clinically led access rather than recreational use—positioning medical cannabis as one option within a broader package of care for complex, long‑term health needs.

Strategic angle for Tilray

Lyphe Clinic became part of Tilray Medical in April 2026, giving Tilray a vertically integrated UK platform that spans clinical services, dispensing, and pharmaceutical distribution. Coupling Lyphe’s digital clinic and pharmacy infrastructure with Tilray’s international supply network allows Tilray Medical to build a more consistent, regulated route for patients to obtain prescribed cannabis‑based medicines, including veteran‑focused programs.

For Tilray, this fits into a broader strategy of positioning its medical division as a provider of clinically supervised access to cannabis across multiple countries, and of using targeted initiatives—like Lyphe for Veterans—to show how medical cannabis can be integrated into formal healthcare pathways rather than sitting at the margins.